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© 2011 The Japan Society of Histochemistry and Expression of aquaporin (AQP) 4 in the surface membranes of skeletal myofibers is well
established; however, its functional significance is still unknown. The alterations of AQP4
expressions in dystrophic muscles at RNA and protein levels have been reported in various
dystrophic muscles such as dystrophinopathy, dysferlinopathy, and sarcoglycanopathy. We
are interested in the relationship between the severity of dystrophic muscle degeneration
and the expression of AQP4. Here we compared the AQP4 expression of the limb muscles
with that of diaphragms in both mdx and control mice. The dystrophic muscle degeneration,
such as rounding profile of cross sectional myofiber shape, dense eosin staining, central
nuclei, and endomysial fibrosis in mdx mice, were more marked in diaphragms than in limb
muscles. The decrease of AQP4 expression at protein level was more marked in diaphragms
than in the limb muscles of mdx mice. However, the expression of AQP4 mRNA in the
diaphragms of mdx mice was not reduced in comparison with limb muscles of mdx mice.
The present study revealed that AQP4 expression at protein level was correlated with the
severity of dystrophic changes in muscle tissues of mdx mice.
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I. Introduction
Aquaporin  (AQP)  4  is  a  water  selective  channel  ex-
pressed in the surface membranes of various kinds of cells
in the different tissues and organs including skeletal muscle
[8, 12, 14, 31]. AQP4 interacts with α1-syntrophin, which
is one of the members of dystrophin complex, in its PDZ
domain, although this is not always the case. Murine X-
linked muscular dystrophy (mdx) and Duchenne muscular
dystrophy (DMD) are caused by genetically homologous
mechanism and both are characterized by a complete absence
of dystrophin, although the limb muscles of adult mdx mice
exhibit less severe myofiber degeneration and fibrosis than
those of DMD limb muscles. Stedman et al. [22] reported
that the mdx mouse diaphragm showed severe degenerative
changes comparable to those of DMD limb muscles. In
addition, they reported that the collagen density in mdx
diaphragm rose to at least seven times higher than that of
control diaphragm and ten times higher than that of mdx
hind-limb muscle [22]. In the limb muscles of the milder
Becker muscular dystrophy, orthogonal array, which is the
morphological feature of AQP4, is less severely depleted in
the sarcolemmal plasma membranes of limb muscles than
those in Duchenne muscular dystrophy [19]. However,
reduced expression of AQP4 was also described in the
skeletal muscles with Fukuyama congenital muscular dys-
trophy (FCMD), sarcoglycanopathy or dysferlinopathy, [2,
3, 30, 31]. Therefore, decreased expression of AQP4 is not
always entirely dependent on the absence of dystrophin and
other factors may also be involved. To test this bypothesis,
we analyzed the degree of AQP4 expression at mRNA and
protein levels in mdx diaphragm in comparison with that of
mdx limb muscle.
II. Materials and Methods
Animals and tissues
Diaphragms and quadriceps femoris muscles wereHara et al. 176
excised from normal mice (n=7; C57BL/6) aged 3 months,
while mdx diaphragms and quadriceps femoris muscles
were obtained from age matched mdx mice (n=5; C57BL/
10ScSn-mdx). The mice were killed by cervical disloca-
tion. All animal experiments were performed in compliance
with the NIH Guide for the Care and Use of Laboratory
Animals and were approved by the ethics committee of
Showa University (admission No. 30005).
Real-time quantitative reverse transcription polymerase chain 
reaction (Real-time quantitative RT-PCR) for mouse AQP4
Total RNA was extracted from approximately 30 mg
of diaphragms and quadriceps femoris muscles from 7
normal (C57BL/6) mice and 5 mdx (C57BL/10ScSn-mdx)
mice with an acid-phenol extraction reagent (TRIzol, code
15596-026; Gibco BRL, Rockville, MD, USA). The
concentration of AQP4 mRNA content was estimated by
real-time quantitative RT-PCR as described previously
[20]. The oligonucleotide primers were designed from
the mouse AQP4 sequence (Entrez U88623): sense strand,
5'-GAAAACCCCTTACCTGTGG-3'; antisense strand, 5'-
AGCTGGCAAAAATAGTGA-3'. To compensate for dif-
ferences in the RNA quality or RT efficacy, the expression
of the glyceraldehyde-3 phosphate dehydrogenase (G3PDH)
gene was quantified as housekeeping gene in each sample.
The oligonucleotide primers for G3PDH were designed
according to the manufacturer’s catalog (Clontech Labo-
ratories Inc., Mountain View, CA, USA): sense strand, 5'-
ACCACAGTCCATGCCATCAC-3'; antisense strand, 5'-
TCCACCACCCTGTTGCTGTA-3'.
For the generation of standard curves of AQP4 and
G3PDH, we synthesized primers by adding T7 promoter
sequence to forward primer and oligo-dT sequence to reverse
primer for both AQP4 and G3PDH genes. The total RNAs
100 ng (1 μl of 100 ng/μl) extracted from mouse skeletal
muscles were reverse transcribed and amplified by PCR
using one step RNA PCR Kit (TaKaRa Bio Inc., Shiga,
Japan, Code RR024A). After gel electrophoresis of the
RT-PCR products, the bands corresponding to AQP4 and
G3PDH cDNAs were extracted and purified. Using these
double stranded DNA as templates, single stranded RNA
was made using In Vitro Transcription T7 Kit (TaKaRa Bio
Inc., Code 6140) and copy number was calculated both in
AQP4 and G3PDH products. The samples of serial dilution
were made with respect to AQP4 and G3PDH RNAs. Before
making the standard curve for AQP4 mRNA, the single
stranded mouse AQP4 mRNA was denatured at 70°C for
10 min and the gel electrophoresis was performed with 1.87
μg of denatured RNA in 2.5% agarose gel. After confirming
the purity of the single stranded AQP4 mRNA, the diluted
samples were reverse transcribed for 10 min at 50°C
followed by 25 cycles of PCR (30 sec and 20 sec at 94°C
and 48°C, respectively, and 30 sec at 72°C) with the reaction
mixture containing 1×PCR buffer, 0.4 μM each of primer
pairs, 5 mM magnesium chloride, 0.8 U/μl ribonuclease
inhibitor, 0.1 U/μl reverse transcriptase, 0.1 U/μl Taq
polymerase and 1 mM dNTP mixture using Real Time One
Step RNA PCR Kit (TaKaRa Bio Inc., Code RR026A) and
Smart Cycler (Cepheid, CA, USA). For the calculation of
the copy numbers of AQP4 mRNAs, the extracted RNA
samples were reverse transcribed and the resultant cDNAs
were amplified by PCR similarly. For making the standard
curve for G3PDH mRNA and the calculation of the copy
numbers of G3PDH mRNAs, the samples were reverse
transcribed for 10 min at 50°C followed by 30 cycles of
PCR (30 sec and 20 sec at 94°C and 62°C, respectively,
and 30 sec at 72°C) in the same reaction mixture described
above. Based on the standard curve, the copy numbers of
mRNAs of G3PDH were calculated. Finally the ratio of
AQP4 mRNA copy number versus G3PDH mRNA copy
number was calculated in each tissue of normal mice and
age-matched mdx mice, and statistically compared by two-
tailed t test. Difference between mean values was considered
significant when p<0.05.
Peptide synthesis and antibody production
General procedures for peptide synthesis and antibody
production were performed as previously described [26,
27]. Briefly the peptides (C-EKKGKDSSGEVLSSV [7]
and GKKDKEKRFSFFPKKK-C [18, 32] of the C-terminal
domains of the rat AQP4 and the human β-spectrin,
respectively, were synthesized. Antibodies against these
peptides were generated in rabbit. An enzyme-linked
immunosorbent assay was used to determine the rabbit
polyclonal antibody titers, which were ×204,800 and
×200,000, respectively.
Immunohistochemistry
Quadriceps femoris muscles and diaphragms from 4
normal mice (C57BL/6) and 4 mdx mice (C57BL/10ScSn-
mdx) were obtained after killing mice by cervical dislocation.
The excised muscle samples were immediately frozen in
isopentane cooled by liquid nitrogen. Six-micrometer-thick
frozen transverse sections of muscles were placed on slide
glasses and incubated with primary antibodies which
included rabbit anti-AQP4 and β-spectrin antibodies [27,
29]. After washing in PBS, the sections were incubated with
FITC-conjugated swine anti-rabbit immunoglobulin [26].
The percentages of AQP4 positive myofibers were
calculated both in the quadriceps femoris muscles and
diaphragm muscles of 4 mdx mice as follows. Serially
sectioned muscle specimens with immunohistochemical
staining by anti-APQ4 and anti-β-spectrin antibodies,
respectively, were photographed. The photographs were
printed at a final magnification of ×350 and those of β-
spectrin immunostaining were used for the calculation of
total myofibers present in the given area, while those of
AQP4 immunostaining were used for the estimation of total
number of AQP4 positive myofibers in the same area. Here
the myofibers with more than 80% surface immunolabeling
by anti-AQP4 antibody were defined as the AQP4 positive
myofibers. Thus the percentage of AQP4 positive myofibers
in each muscle of 4 quadriceps femoris muscles and 4
diaphragm muscles of 4 mdx mice was obtained. TheAQP4 Expression in the mdx Mouse Diaphragm 177
Table 1. Real-time quantitative RT-PCR analysis in the quadriceps femoris muscle and diaphragm of 
wild-type and mdx mice
* Group mean±standard error of the mean
*1 versus *3: p>0.1
*2 versus *4: p<0.01
*1 versus *2: p<0.05
*3 versus *4: p<0.01 (two tailed t-test)
AQP4 mRNA copy number
G3PDH mRNA copy number
Wild-type mice (n=7) Diaphragm 0.17±0.02*1
Quadriceps femoris muscle 0.11±0.01*2
Mdx mice (n=5) Diaphragm 0.12±0.01*3
Quadriceps femoris muscle 0.01±0.01*4
Fig. 1. The immunostaining of serial sections of normal quadriceps femoris muscle with anti-AQP4 (A) and β-spectrin (B) antibodies. The
normal quadriceps femoris myofibers show the basically immunopositive reaction with both antibodies, although the immunoreactivity with
anti-AQP4 antibody is a little bit weaker in some myofibers (A) in comparison with that of anti-β-spectrin antibody (B). The myofiber with
asterisk in A and B is the same myofiber. Bar=20 μm (A, B ×400).Hara et al. 178
difference in the group mean percentages of 4 quadriceps
femoris muscles and 4 diaphragm muscles was statistically
compared by two tailed t-test. Difference between mean
values was considered significant when p<0.05.
III. Results
Real-time quantitative RT-PCR of AQP4 mRNA
The relative AQP4 mRNA levels in quadriceps femoris
muscles and diaphragms of normal mice were 0.11±0.01
and 0.17±0.02, respectively, while those of mdx mice were
0.01±0.01 and 0.12±0.01, respectively (Table 1). The AQP4
mRNA levels of diaphragms were slightly higher than those
of quadriceps femoris muscles in normal mice (0.01<p<0.05
by two tailed t-test). However, the AQP4 mRNA levels of
quadriceps femoris muscles in mdx mice were significantly
lower than those of normal mice (p<0.01), although the
levels of diaphragms between normal and mdx mice were
not (p>0.1).
Immunohistochemistry
The immunostaining of normal quadriceps femoris
muscles with anti-AQP4 antibody showed most of the
myofiber surface membranes were positively stained with
this antibody (Fig. 1A). The immunohistochemistry with
anti-β-spectrin antibody of serial section of normal quadri-
Fig. 2. The immunostaining of serial sections of normal diaphragm muscle with anti-AQP4 (A) and β-spectrin (B) antibodies. The normal
diaphragm myofibers reveal the immunopositive reaction with both antibodies, although the immunoreactivity with anti-AQP4 antibody
appears slightly discontinuous in comparison with that of anti-β-spectrin antibody (B). Higher magnification of A (inset: I) shows the dot-like
immunoreactivity of myofiber surface membrane with anti-AQP4 antibody. The myofiber with asterisk in A and B is the same myofiber.
Bar=20 μm (A, B ×400, I ×800).AQP4 Expression in the mdx Mouse Diaphragm 179
ceps femoris muscles revealed that the surface membranes
of all the myofibers were immunostained continuously with
this antibody (Fig. 1B). The normal diaphragm myofibers
revealed the immunopositive reaction at the myofiber sur-
face with both anti-AQP4 and β-spectrin antibodies (Fig.
2A, B), although the immunoreactivity with anti-AQP4
antibody appeared to be slightly discontinuous (Fig. 2I).
In the quadriceps femoris muscle sections of mdx mice,
the immunoreactivity with anti-AQP4 antibody (Fig. 3A)
was reduced in comparison with that of quadriceps femoris
muscles of normal mice (Fig. 1A). The mdx quadriceps
femoris myofibers showed a negative or partially positive
immunoreactivity with anti-AQP4 antibody (Fig. 3A). The
immunostaining of mdx quadriceps femoris myofibers
with anti-β-spectrin antibody revealed the positive staining
in all myofibers (Fig. 3B). In the diaphragm sections of
mdx mice, most of the myofibers demonstrated a negative
or minimally immunopositive staining with anti-AQP4
antibody (Fig. 4A). The immunonegativity of anti-AQP4
antibody was more marked in mdx diaphragm myofibers
(Fig. 4A) in comparison with that of mdx quadriceps femoris
myofibers (Fig. 3A). The immunohistochemistry of mdx
diaphragm myofibers with anti-β-spectrin antibody showed
that most of the mdx diaphragm myofibers were immuno-
positive with this antibody (Fig. 4B), although the immuno-
reactivity was somewhat irregular (Fig. 4B).
Fig. 3. The immunostaining of serial sections of mdx quadriceps femoris muscle with anti-AQP4 (A) and β-spectrin (B) antibodies. In the
mdx quadriceps femoris muscle sections, the immunoreactivity with anti-AQP4 antibody (A) is reduced in comparison with that of normal
quadriceps femoris muscle (Fig. 1A) and most of the mdx myofibers show the negative or partially positive immunoreactivity with this
antibody (A). The immunostaining of mdx quadriceps femoris myofibers with anti-β-spectrin antibody revealed the positive staining in all
myofibers (B). Bar=20 μm (A, B ×400).Hara et al. 180
The semiquantitative study showed that the group mean
percentage±standard error of the mean of AQP4 positive
myofibers was 19.4±4.2 and 5.8±2.2 in the quadriceps
femoris muscles and diaphragm muscles of 4 mdx mice,
respectively. These percentages were significantly different
(p<0.03)
IV. Discussion
Although both mdx mouse and DMD are characterized
by a complete absence of dystrophin, the clinical phenotype
is rather different and the disability of mdx mouse is very
mild. The difference of running ability between mdx and
normal mice is difficult to evaluate without using instruments
[6]. Pathologically speaking, the limb muscles of mdx mouse
reveal milder dystrophic changes than those of DMD.
Furthermore, less marked myofiber degeneration and inter-
stitial fibrosis, and more sarcolemmal expression of AQP4
are characteristic features in limb muscle of mdx mice [11].
The pathomechanism of this difference between mdx and
DMD muscles is unknown. It is also unclear why the
different muscles, such as limb muscle and diaphragm of
mdx mouse, show the different degrees of severity of
dystrophic changes. Mdx myofibers lack sarcolemmal
Fig. 4. The immunostaining of serial sections of mdx diaphragm with anti-AQP4 (A) and β-spectrin (B) antibodies. Most of the mdx diaphragm
myofibers demonstrated a negative or minimally immunopositive staining with anti-AQP4 antibody (A). The immunonegativity of anti-AQP4
antibody is more marked in mdx diaphragm myofibers in comparison with that of mdx quadriceps femoris myofibers (Fig. 3A). The myofibers
indicated by asterisk and arrow (A and B) reveal that the myofiber with asterisk (A) shows the positive AQP4 immunostaining and the myofiber
indicated by arrow (A) reveals the negative AQP4 immunoreactivity, respectively, although both myofibers are immunopositive with anti-β-
spectrin antibody (B). The myofiber surface immunoreactivity with anti-β-spectrin antibody was somewhat irregular (B). Bar=20 μm (A, B
×400).AQP4 Expression in the mdx Mouse Diaphragm 181
dystrophin, which is abundant at the costamere in normal
myofibers [13, 15, 17, 23, 28]. Although it is not always
the case, AQP4 interacts with α1-syntrophin, one of the
members of dystrophin complex, with its postsynaptic
density-95, Drosophila disc large protein and the Zona
occludens protein I protein-interaction (PDZ) domain [1].
Consequently, the intrinsic membrane protein AQP4 is more
abundantly present at the costameres where β-spectrin is
also concentrated [18].
Dystrophic myofibers often lack the sarcolemmal
plasma membrane [16] where β-spectrin is expressed. In
this study β-spectrin immunostaining was performed in order
to confirm the presence of sarcolemmal plasma membranes
without expressing AQP4 protein in dystrophic mdx mice.
Dystrophin-deficient mdx mouse muscle and DMD muscle
are thought to lack dystrophin complex, resulting in the
absence of α1-syntrophin. This in turn relates to the
decreased expression of AQP4 in the muscles of mdx mice
and DMD boys. Although decreased, the degree of the
reduced expression of AQP4 at protein level is milder in
the limb muscle of mdx mouse than in the quadriceps femoris
muscle of DMD [11]. However, a substantial amount of
AQP4 protein is expressed in mdx quadriceps femoris
muscles. This suggests that the AQP4 anchoring proteins
other than α1-syntrophin are present at the mdx myofiber
surface. At RNA level, a normal level of AQP4 mRNA in
mdx muscle was reported [4]. The level of AQP4 mRNA
in the diaphragm of mdx mouse was not different statistically
from that of normal mouse in the present study, although it
was statistically reduced in the quadriceps femoris muscle
of mdx mouse in comparison with that of normal mouse.
This may be due to more active myofiber degeneration and
regeneration in the mdx diaphragm [24]. Moreover, AQP4
mRNA level analysis of diaphragms and quadriceps femoris
muscles of mdx mice implied that AQP4 anchoring proteins
other than α1-syntorophin, if present, may also be more
markedly reduced in diaphragms than in the quadriceps
femoris muscles of mdx mice.
In freeze fracture electron microscopy, a decreased
density of orthogonal arrays was observed in the muscles
of FCMD which is severe muscular dystrophy [25].
Following this study, we studied the AQP4 expression in
the muscles of FCMD with normal dystrophin expression,
and reported the decreased expression of AQP4 in the
muscles with FCMD [30].
Studies of AQP4 expression in other dystrophic mus-
cles also showed the reduced expression of AQP4 in
the muscles with α-dystroglycanopathy [1], dysferlinopathy
[2] or sarcoglycanopathy [3]. Au et al. [2] suggested that
altered AQP4 expression observed in the dystrophic muscle
biopsies are likely secondary to the dystrophic process. The
present results revealed that the decrease of AQP4 protein
was more marked in the diaphragm muscles than in the
limb muscles of mdx mice. The immature muscle cells do
not express AQP4 at their surface membranes and one of
the factors to express AQP4 is nerve influence [9, 10, 21].
The interstitial fibrosis of skeletal muscle tissue is more
marked in mdx diaphragm than in mdx limb muscle [22].
Myofibrosis is a complex and incompletely understood
process characterized by excessive accumulation of collagen
IV and other extracellular matrix components. Excessive
collagen accumulation in the mdx diaphragm is associated
with dystrophic increase in the expression of transforming
growth factor β1 (TGF-β1) without corresponding increase
in matrix metalloproteinase-9 (MMP-9) expression [5].
The axonal growth of spinal motor neuronal cells may be
inhibited by the interstitial myofibrosis of muscle tissues of
mdx mice. Thus, the regenerating myofibers may be more
dysinnervated in the mdx diaphragm than in the mdx limb
muscle after myofiber degeneration and necrosis. Finally,
the present study suggested that the more marked decrease
of AQP4 protein observed in the mdx diaphragm muscles
are likely secondary to the dystrophic process in addition
to the lack of dystrophin.
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